Vascular endothelial growth factor (VEGF) is released from platelets during blood clotting: Implications for measurement of circulating VEGF levels in clinical disease

Clinical Science

Volumn 94, Issue 4, 1998, Pages 395-404

  Webb, Nicholas J A ^a,b   Bottomley, Martyn J ^a   Watson, Carolyn J ^a   Brenchley, Paul E C ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Immunoassays; Platelets; Vascular endothelial growth factor; Vascular permeability factor

Indexed keywords

BETA ACTIN; CALCIUM; MESSENGER RNA; THROMBIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ADULT; AGE; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOASSAY; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA;

EID: 0031966498     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0940395     Document Type: Article

References (30)

1. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterisation of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci USA 1989; 86: 7311-15.
2. Senger DR, Galli SS, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumour cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science (Washington DC) 1983; 219: 983-5.
3. Conn G, Bayne ML, Soderman DD, et al. Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proc Nad Acad Sci USA 1990; 87: 2628-32.
4. de Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science (Washington DC) 1992; 255: 989-91.
5. Terman BI, Dougher-Vermazen M, Carrion ME, et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187: 1579-86.
6. Kendall RL, Thomas KA. Inhibition of vascular endothelial growth factor activity by an endogenously encoded soluble receptor. Proc Natl Acad Sci USA 1993; 90: 10705-9.
7. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-39.
8. Fava RA, Olsen NJ, Spencer-Green G, et al. Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue. J Exp Med 1994; 180: 341-6.
9. Bottomley MJ, Holt PLJ, Watson CJ, Webb NJA, Brenchley PEC. Vascular endothelial growth factor mediates synovial inflammation. Arthritis Rheumatism 1996; 39(Suppl. 9) S131.
10. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor - A cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994; 152: 4149-56.
11. Ferrara N. Vascular endothelial growth factor - The trigger for neovascularization in the eye. Lab Invest 1995; 72: 615-18.
12. Adamis AP, Miller JW, Bernal MT, et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol 1994; 118: 445-50.
13. Brenchley PEC. VPF/VEGF: a modulator of microvascular function with potential roles in glomerular pathophysiology. J Nephrol 1996; 9: 1-8.
14. Neulen J, Yan ZP, Raczek S, et al. Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: Importance in ovarian hyperstimulation syndrome. J Clin Endocrinol Metab 1995; 80: 1967-71.
15. Baker PN, Krasnow J, Roberts JM, Yeo KT. Elevated serum levels of vascular endothelial growth factor in patients with preeclampsia. Obstetrics Gynecol 1995; 86: 815-21.
16. Kondo S, Asano M, Matsuo K, Ohmori I, Suzuki H. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim Biophys Acta 1994; 1221: 211-14.
17. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 26031-7.
18. Yeo KT, Sioussat TM, Faix JD, Senger DR, Yeo TK. Development of time-resolved immunofluorometric assay of vascular permeability factor. Clin Chem 1992; 38: 71-5.
19. Hanatani M, Tanaka Y, Kondo S, Ohmori I, Suzuki H. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotechnol Biochem 1995; 59: 1958-9.
20. Mohle R, Green D, Moore MAS, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-8.
21. British Society for Haematology; BCSH Haemostasis and Thrombosis Task Force. Guidelines on platelet function testing. J Clin Pathol 1988; 41: 1322-30.
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
23. Iijima K, Yoshikawa N, Connolly DT, Nakamura H. Human mesangial cells and peripheral blood mononuclear cells produce vascular permeability factor. Kidney Int 1993; 44: 959-66.
24. Power CA, Clemetson JM, Clemetson KJ, Wells TNC. Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine 1995; 7: 479-82.
25. Casscells W. Growth factor therapies for vascular injury and ischaemia. Circulation 1995; 91: 2699-702.
26. 164 in patient with ischaemic limb. Lancet 1996; 348: 370-4.
27. Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y. Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in haemopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionising radiation. Cancer Res 1995; 55: 5687-92.
28. Charnock-Jones DS, Sharkey AM, Rajput-Williams J, et al. Identification and localisation of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Bidol Reprod 1993; 48: 1120-8.
29. Barleon B, Sozzani S, Zhou D, Weich HA, Manovani A, Marme D. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated by the VEGF receptor fit-1. Blood 1996; 87: 3336-43.
30. vβ3, osteopontin and thrombin. Am J Pathol 1996; 149: 293-305.